Douglas Hawkins is an Oncology physician affiliated with Seattle Children's Hospital. OpenAlex indexes 486 publications with 21,771 citations (h-index 71); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4800 Sand Point Way NE
Seattle, WA 981053901
Telephone
206-987-2000Registry record last updated 8 Jul 2007.
Clinical trials
- Project: Every Child for Younger Patients With Cancer
Sponsor: Children's Oncology Group
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Sponsor: Children's Oncology Group
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Sponsor: Children's Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Fennec Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 1999–2007 per NIH RePORTER. The latest:
- CHMC B008: PHARMACOKINETIC AND PHARMOCOGENETICS OF CYCLOPHOSPHAMIDE
University of Washington
FY2007$838M01RR000037 - FILGRASTIM-SD/01 VS FILGRASTIM IN NEWLY DIAGNOSED CHILDREN WITH SARCOMA
University of Washington
FY2006$4,962M01RR000037
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C
JNCI Journal of the National Cancer Institute
2023 - Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium
Journal of Clinical Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Margaret Rosenfeld, MD, MPH
Seattle Children's Hospital
Christopher Blosser, MD
Seattle Children's Hospital
Sarah Leary, MD
Seattle Children's Hospital
Danielle Zerr
Seattle Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”